About the Journal
Annals of Translational Medicine
Aims and Scope
Annals of Translational Medicine (Ann Transl Med; ATM; Print ISSN 2305-5839; Online ISSN 2305-5847) is an international, peer-reviewed, open-access journal, aiming to provide practical, up-to-date information on the significant research from all subspecialties of medicine and broaden the readers' vision and horizon from bench to bedside and bedside to bench. It was published quarterly (April 2013 to December 2013), monthly (January 2014 to February 2015), and then biweekly (March 2015 onwards). It is also openly distributed worldwide.
Annals of Translational Medicine is indexed in PubMed in Sept 2014 and in SCIE in 2018 (2018 Impact Factor: 3.689; 2019 Impact Factor: 3.297; 2020 Impact Factor: 3.932; 2021 Impact Factor: 3.616). Specific areas of interest include, but not limited to, multimodality therapy, epidemiology, biomarkers, imaging, biology, pathology, and technical advances related to medicine. Submissions describing preclinical research with potential for application to human disease, and studies describing research obtained from preliminary human experimentation with potential to further the understanding of biological mechanism underlying disease are encouraged. Also warmly welcome are studies describing public health research pertinent to clinic, disease diagnosis and prevention, or healthcare policy.
With a focus on interdisciplinary academic cooperation, ATM aims to expedite the translation of scientific discovery into new or improved standards of management and health outcomes practice.
Information for Authors
ATM is a member of Committee on Publication Ethics (COPE) and it follows the Committee on Publication Ethics (COPE)'s guidelines and the ICMJE recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journal.
Manuscripts submitted must be the original work of the author(s) and must not be published previously or under consideration for publication elsewhere.
Submission Turnaround Time
- In-house review: 1-3 weeks
- External peer review: 1-3 months
- Publication Ahead of Print: within 1 month after being accepted
- Formal publication: within 1-3 months after being accepted. Original Articles are listed as priority.
ATM is the Official Publication of:
- Society for Translational Medicine (STM), Hong Kong
ATM is endorsed by the Bonnie J. Addario Lung Cancer Foundation (ALCF), the Ming-Yi Medical Charity Foundation of Guangdong Province, the international Inspire2Live Patient Advocates organization, and the Hellenic Cooperative Oncology Group (HeCOG).
Open Access Statement
This journal is a peer reviewed, open access journal. All content of the journal is published under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0). All articles published open access will be immediately and permanently free for all to read, download, copy and distribute as defined by the applied license.
Free access and usage
Permitted third party reuse is defined by the CC BY-NC-ND 4.0 license. This license allows users to copy and distribute the article, provided:
- this is not done for commercial purposes and further does not permit distribution of the Article if it is changed or edited in any way.
- the user gives appropriate credit (with a link to the formal publication through the relevant DOI) and provides a link to the license but not in an any way implying that the licensor is endorsing the user or the use of the work.
- no derivatives including remix, transform, or build upon the material was allowed for distribution.
The full details of the license are available at https://creativecommons.org/licenses/by-nc-nd/4.0/
For open access publishing, this journal uses an exclusive licensing agreement. Authors will transfer copyright to ATM, but will have the right to share their article in the same way permitted to third parties under the relevant user license, as well as certain scholarly usage rights.
For any inquiry/special circumstance on the copyright, commercial usage or adaptation of ATM articles, please contact: firstname.lastname@example.org
For reprint order, please contact: email@example.com
ATM is published by AME Publishing Company.
Address: Flat/RM C 16F, Kings Wing Plaza 1, NO. 3 on Kwan Street, Shatin, NT, Hong Kong, China.
Updated on June 29, 2022